Atlas Venture Opportunity Fund I, L.p.

Affiliations

  • at Q32 Bio Inc. (QTTB), 2024-03-27
  • Large Shareholder at Kymera Therapeutics Inc. (KYMR), 2024-03-13
  • at Dyne Therapeutics Inc. (DYN), 2024-03-05
  • Large Shareholder at Xilio Therapeutics Inc. (XLO), 2024-02-09
  • Large Shareholder at Disc Medicine Inc. (IRON), 2024-01-25
  • Large Shareholder at Third Harmonic Bio Inc. (THRD), 2022-09-19
  • Large Shareholder at Day One Biopharmaceuticals Inc. (DAWN), 2022-07-06
  • Large Shareholder at Vigil Neuroscience Inc. (VIGL), 2022-01-12
  • Large Shareholder at Ikena Oncology Inc. (IKNA), 2021-12-15
  • Large Shareholder at Generation Bio Co. (GBIO), 2021-09-29
  • Other at Magenta Therapeutics Inc. (MGTA), 2020-07-13
  • Large Shareholder at Akero Therapeutics Inc. (AKRO), 2020-02-11
  • Other at Replimune Group Inc. (REPL), 2019-11-20
  • Other at Avrobio Inc. (AVRO), 2019-07-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DYN $30.05 17,099 847,388 2024-03-01 Filing
DYN $30.05 29,435 1,458,691 2024-03-01 Filing